CoChat

Effect of Psilocybin on Empathy and Moral Decision-Making

Open access
Pokorny, Thomas, Preller, Katrin H, Kometer, Michael, Dziobek, Isabel, Vollenweider, Franz X · 2017 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.

Abstract

Background: Impaired empathic abilities lead to severe negative social consequences and influence the development and treatment of several psychiatric disorders. Furthermore, empathy has been shown to play a crucial role in moral and prosocial behavior. Although the serotonin system has been implicated in modulating empathy and moral behavior, the relative contribution of the various serotonin receptor subtypes is still unknown. Methods: We investigated the acute effect of psilocybin (0.215 mg/kg p.o.) in healthy human subjects on different facets of empathy and hypothetical moral decision-making using the multifaceted empathy test (n=32) and the moral dilemma task (n=24). Results: Psilocybin significantly increased emotional, but not cognitive empathy compared with placebo, and the increase in implicit emotional empathy was significantly associated with psilocybin-induced changed meaning of percepts. In contrast, moral decision-making remained unaffected by psilocybin. Conclusions: These findings provide first evidence that psilocybin has distinct effects on social cognition by enhancing emotional empathy but not moral behavior. Furthermore, together with previous findings, psilocybin appears to promote emotional empathy presumably via activation of serotonin 2A/1A receptors, suggesting that targeting serotonin 2A/1A receptors has implications for potential treatment of dysfunctional social cognition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyx047

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Psychological effects of psilocybin. (A) Scores of the Altered States of Consciousness Rating Scale (5D-ASC) scales (n=32). Psilocybin significantly increased all scale scores compared with placebo (all P<.05), except for anxiety (P>.8). (B) Scores of the Positive and Negative Affect Schedule (PANAS) (n=31). Mood states compared from pre to post (360 minutes after drug intake). Psilocybin significantly increased positive mood (P<.05) but not negative mood (P>.8), whereas placebo had no effects on the mood scales (all P>.2). Data are expressed as mean ± SEM. *P<.05, **P<.0001.
Figure 1. Psychological effects of psilocybin. (A) Scores of the Altered States of Consciousness Rating Scale (5D-ASC) scales (n=32). Psilocybin significantly increased all scale scores compared with placebo (all P<.05), except for anxiety (P>.8). (B) Scores of the Positive and Negative Affect Schedule (PANAS) (n=31). Mood states compared from pre to post (360 minutes after drug intake). Psilocybin significantly increased positive mood (P<.05) but not negative mood (P>.8), whereas placebo had no effects on the mood scales (all P>.2). Data are expressed as mean ± SEM. *P<.05, **P<.0001.CC BY-NC · PubMed Central
Figure 2. Multifaceted empathy test (MET). (A) Psilocybin significantly increased the mean rating of explicit and implicit emotional empathy (each P < .01) compared with placebo regardless of the valence of the stimuli. (B) No significant effect of psilocybin on the mean of correct answers of cognitive empathy (P > .2) compared with placebo were found. In general, participants made significantly more mistakes for negative stimuli than positive stimuli (P < .05). Data are expressed as mean ± SEM in 32 subjects. *P < .05.
Figure 2. Multifaceted empathy test (MET). (A) Psilocybin significantly increased the mean rating of explicit and implicit emotional empathy (each P < .01) compared with placebo regardless of the valence of the stimuli. (B) No significant effect of psilocybin on the mean of correct answers of cognitive empathy (P > .2) compared with placebo were found. In general, participants made significantly more mistakes for negative stimuli than positive stimuli (P < .05). Data are expressed as mean ± SEM in 32 subjects. *P < .05.CC BY-NC · PubMed Central
Figure 3. Mean ration of utilitarian choices in 3 different moral dilemma categories from the moral dilemma task (MDT). No effects of psilocybin on moral dilemmas were found. Categories: personal moral avoidable (PM AV); personal moral inevitable (PM IN); impersonal moral (IPM). Data are expressed as mean ± SEM in 24 subjects.
Figure 3. Mean ration of utilitarian choices in 3 different moral dilemma categories from the moral dilemma task (MDT). No effects of psilocybin on moral dilemmas were found. Categories: personal moral avoidable (PM AV); personal moral inevitable (PM IN); impersonal moral (IPM). Data are expressed as mean ± SEM in 24 subjects.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 1963, LSD in the treatment of criminal psychopaths
  2. 1994, Aussergewöhnliche Bewusstseinszustände - Ihre gemeinsame Struktur und Messung [Altered states of consciousness - Their common structure and assessment], 45
  3. 1968, Use of psychedelic drugs in prisoner rehabilitation, Br J Soc Psychiatry, 2, 27

Cited by

See all 197

Metadata

Authors
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X.
Affiliations
University of Zurich (CH)
Corresponding author
Pokorny, Thomas
Venue
International Journal of Neuropsychopharmacology
Published
2017-06-16
Volume
20
Issue
9
Pages
747-757
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2624901555
Cited by
197
References
73
Citations by year
2026: 17 · 2025: 21 · 2024: 40 · 2023: 27 · 2022: 27 · 2021: 24 · 2020: 20 · 2019: 9 · 2018: 11 · 2017: 1
FWCI
13.91
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
  • reroDoc Digital Library (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Heffter Research Institute (1‐190413)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
psilocybin, empathy, ethical decision-making, affective empathy, cognitive empathy, 5-HT2A receptor, 5-HT1A receptor, social cognition, ethical dilemmas, altered perception, psychedelics
MeSH terms
Adult, Analysis of Variance, Decision Making, Double-Blind Method, Empathy, Female, Hallucinogens, Humans, Male, Morals, Neuropsychological Tests, Psilocybin, Young Adult, Self Report, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.